Copyright
        ©2005 Baishideng Publishing Group Inc.
    
    
        World J Gastroenterol. May 14, 2005; 11(18): 2744-2747
Published online May 14, 2005. doi: 10.3748/wjg.v11.i18.2744
Published online May 14, 2005. doi: 10.3748/wjg.v11.i18.2744
		Figure 1 Immunohistochemical staining of pBcl-2 and pBax in pancreatic cancer (original magnification, ×200).
		
			 A: pBcl-2 immunostaining was stained in cytoplasm of tumor cells; B: pBax immunostaining was stained in cytoplasm of tumor cells.
		
	
		Figure 2 Survival curves with Kaplan-Meier method was applied in analyzing the influence of pBcl-2, pBax and their combined expression on post-surgical survival time.
		
			
		
	
- Citation: Dong M, Zhou JP, Zhang H, Guo KJ, Tian YL, Dong YT. Clinicopathological significance of Bcl-2 and Bax protein expression in human pancreatic cancer. World J Gastroenterol 2005; 11(18): 2744-2747
- URL: https://www.wjgnet.com/1007-9327/full/v11/i18/2744.htm
- DOI: https://dx.doi.org/10.3748/wjg.v11.i18.2744

 
         
                         
                 
                 
                 
                 
         
                         
                         
                         
                         
			